CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Roxane Laboratories, Inc. et al. vs. Novartis AG

Explore the PTAB proceeding IPR2016-01461 filed by Roxane Laboratories, Inc. et al. on 2016-07-19. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2016-01461

Filing Date

2016-07-19

Accorded Filing Date

2016-07-19

Institution Decision Date

2017-02-13

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

โ€”

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 12094173
Respondent Patent Number 9006224
Legal Expiration Date
2028-07-01 Active (1.6 yrs remaining)
Patent Term Adjustment (PTA) +589 Days Awarded
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Peter Wayne Marks et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

32 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name NOVARTIS PHARMACEUTICAL CORPORATION - INTELLECTUAL PROPERTY DEPARTMENT
Customer Number 1095
Address 250 Massachusetts Avenue, Cambridge, MA, 02139, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
39030 Jean Silveri +1 617-871-5134
40232 Timothy Witkowski +1 617-301-1869
43228 Peter Waibel +1 862-778-7838
46473 Emily Wu +1 858-812-1539
46593 Laurie Lawrence +1 617-871-8584
48631 Carol Fang +1 650-467-2901
51681 Mark Flanigan +1 817-615-5080
53504 Daniel Raymond +1 858-812-1617

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 3 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): ๐Ÿ‡ช๐Ÿ‡บ Europe GB ๐Ÿ‡บ๐Ÿ‡ธ US ๐ŸŒ PCT
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 3
USPTO PTAB Trial 2017-03-13
IPR2017-01078

West-Ward Pharmaceuticals International Limited v. Novartis AG

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2017-03-10
IPR2017-01063

Argentum Pharmaceuticals LLC et al. v. Novartis AG

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-07-22
IPR2016-01479

Par Pharmaceutical, Inc. et al. v. Novartis AG

Asserted Patent
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

68
11

Notice of Refund Paper

2017-03-31 FILING PARTY: BOARD
10

Request for Refund of Post-Institution Fees for Inter Partes Review of U.S. Patent No, 9006224 Paper

2017-03-20 FILING PARTY: PETITIONER
9

Decision - Denying Institution of Inter Partes Review - 35 USC 314(a) and 37 CFR 42.108 Paper

2017-02-13 FILING PARTY: BOARD
8

Petitioner's Updated Mandatory Notice Paper

2017-01-11 FILING PARTY: PETITIONER
2006

Ex. 2006 - Hewitt and Yu Exhibits

2016-11-14 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc